StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
APYX

Apyx Medical Corporation

APYX Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗
$4.18
+0.06 +1.46%

Key statistics

from XBRL data in SEC filings
Market cap
$175M
Revenue (TTM)
$55.9M
Net income (TTM)
-$9.17M
EPS (TTM)
$-0.22
P/E ratio
Dividend yield
Free cash flow
-$9.12M
Cash
$31.1M
Total assets
$63.0M
Gross margin
63.2%
52-week range
$1.70 – $5.08

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jul 24, 2026 8-K Entered a material agreement Jun 17, 2026 8-K Other events May 21, 2026 8-K Other events May 14, 2026 8-K Other events May 11, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 10, 2026 8-K Results of operations (earnings release) Mar 10, 2026 8-K Results of operations (earnings release) Jan 12, 2026 8-K Amended charter or bylaws Dec 12, 2025 8-K Entered a material agreement; Other events Nov 19, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Shareholder vote results Aug 13, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Other events May 13, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Other events Apr 29, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Results of operations (earnings release) Mar 13, 2025 8-K Director or officer change Feb 6, 2025 8-K Results of operations (earnings release) Jan 13, 2025 8-K Other events Jan 6, 2025 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Unregistered sale of equity; Director or officer change; Other events Nov 8, 2024 8-K Shareholder vote results Aug 12, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Entered a material agreement; Director or officer change May 9, 2024 10-K Fiscal year ended 2023-12-31 Mar 21, 2024 8-K Results of operations (earnings release) Mar 21, 2024 8-K Other events Feb 21, 2024 8-K Other events Jan 22, 2024 8-K Results of operations (earnings release) Jan 8, 2024 8-K Director or officer change; Regulation FD disclosure Nov 28, 2023